Current Trends in Cardiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Rapid Communication - Current Trends in Cardiology (2024) Volume 8, Issue 2

Cardiac Hypertrophy: Causes, Symptoms, and Management Approaches

Devesh Rai *

Department of Cardiology, Sands Constellation Heart Institute, Rochester, New York.

*Corresponding Author:
Devesh Rai
Department of Cardiology
Sands Constellation Heart Institute, Rochester
New York
E-mail: Deveshr@gmail.com

Received:27-Jan-2024,Manuscript No. AACC-24-135486; Editor assigned:01-Feb-2024,PreQC No. AACC-24-135486(PQ); Reviewed:15-Feb-2024,QC No. AACC-24-135486; Revised:22-Feb-2024, Manuscript No. AACC-24-135486(R); Published:29-Feb-2024,DOI:10.35841/aacc-8.2.254

Citation:Rai D. Cardiac hypertrophy: Causes, symptoms, and management approaches. 2024;8(2):254.

Visit for more related articles at Current Trends in Cardiology

Introduction

Cardiac hypertrophy is a condition characterized by an enlargement or thickening of the heart muscle. While it can sometimes be a beneficial adaptation to increased workload, it often represents an underlying pathology and can lead to serious complications if left untreated. In this article, we delve into the causes, symptoms, and management approaches for cardiac hypertrophy, shedding light on this complex cardiovascular condition. Cardiac hypertrophy can be triggered by various factors, both physiological and pathological. One common cause is chronic hypertension, where the heart must work harder to pump blood against elevated resistance in the arteries. This increased workload leads to the thickening of the heart muscle over time. [1,2].

Another cause is valvular heart disease, such as aortic stenosis or mitral regurgitation, which can disrupt normal blood flow and force the heart to compensate by hypertrophying. Additionally, conditions like hypertrophic cardiomyopathy (HCM), a genetic disorder characterized by abnormal thickening of the heart muscle, can also lead to cardiac hypertrophy. It's important to note that symptoms can vary depending on the underlying cause of hypertrophy and the extent of heart muscle thickening. In some cases, cardiac hypertrophy may remain asymptomatic until complications arise, such as heart failure or arrhythmias. [3,4].

Adopting a heart-healthy lifestyle can help manage cardiac hypertrophy and reduce the risk of complications. This includes maintaining a balanced diet low in saturated fats and sodium, engaging in regular physical activity, maintaining a healthy weight, avoiding tobacco use, and limiting alcohol consumptionPharmacological therapy may be prescribed to manage symptoms and reduce the workload on the heart. [5,6].

In some instances, implantable devices such as pacemakers or implantable cardioverter-defibrillators (ICDs) may be recommended to regulate heart rhythm or prevent sudden cardiac deathCardiac rehabilitation programs can provide structured exercise training, education, and psychosocial support to individuals with cardiac hypertrophy, helping them improve their cardiovascular fitness and overall quality of life.[7,8].

Cardiac hypertrophy, the thickening of the heart muscle, arises from various factors including chronic hypertension, valvular heart disease, and genetic predispositions like hypertrophic cardiomyopathy. Initially asymptomatic, it progresses to manifest symptoms such as shortness of breath, fatigue, and chest discomfort. Management strategies encompass lifestyle modifications such as a heart-healthy diet and regular exercise, alongside pharmacological interventions like ACE inhibitors and beta-blockers to alleviate symptoms and reduce strain on the heart. Surgical options like valve repair and septal myectomy may be necessary in certain cases, while implantable devices offer additional support. Cardiac rehabilitation programs provide essential guidance and support for individuals, emphasizing the importance of early detection and comprehensive management to mitigate complications and improve overall cardiac health. [9,10].

Conclusion

 

Cardiac hypertrophy is a complex condition with multiple underlying causes and manifestations. Early detection and management are crucial to prevent complications such as heart failure, arrhythmias, and sudden cardiac death. By addressing contributing factors, adopting a healthy lifestyle, and following a comprehensive treatment plan tailored to individual needs, individuals with cardiac hypertrophy can effectively manage their condition and optimize their cardiac health.

 

References

  1. Cohen MC, Aretz TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction.Cardiovasc Pathol. 1999;8:133–39.

    2. Indexed at, Google Scholar, Cross Ref

  2. Orhan AL. Atrial fibrillation as a preoperative risk factor predicts long-term mortality in elderly patients without heart failure and undergoing hip fracture surgery.. Rev Assoc Med Bras. 2021; 67:1633–38.

    3. Indexed at, Google Scholar, Cross Ref

  3. Waxman S. Plaque disruption and thrombus in Ambrose's angiographic coronary lesion types.. Am J Cardiol. 2003; 92:16–20.

    4. Google Scholar, Cross Ref

  4. Sheth T. Incidence of thrombosis in perioperative and non-operative myocardial infarction.. Br J Anaesth. 2018; 120:725–733.

    5. Indexed at, Google Scholar, Cross Ref

  5. Landesberg G. Perioperative myocardial infarction. Circulation . 2009;119:2936–44.

    6. Indexed at, Google Scholar, Cross Ref

  6. Zhou W. Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis.J Nucl Cardiol. 2021;28:579–88.

    7. Indexed at, Google Scholar, Cross Ref

  7. Zhao G. ATP- and voltage-dependent electro-metabolic signaling regulates blood flow in heart. . Proc Natl Acad Sci U S A. 2020;117:7461–70.

    8. Indexed at, Google Scholar, Cross Ref

  8. Zhang P. NADPH oxidase contributes to coronary endothelial dysfunction in the failing heart.. Am J Physiol Heart Circ Physiol. 2009;296:H840–H846.

    9. Google Scholar, Cross Ref

  9. Zhang J. Relationships between myocardial bioenergetic and left ventricular function in hearts with volume-overload hypertrophy.. Circulation. 1997;96:334–343.

    10. Indexed at, Google Scholar, Cross Ref

  10. Zelis JM. Coronary microcirculation in aortic stenosis: pathophysiology, invasive assessment, and future directions . J Interv Cardiol. 2020;2020:4603169.

    11. Indexed at, Google Scholar, Cross Ref

     

Get the App